Skip to content

Comparison of ARPE Prosthesis With the Literature

Trapezio-metacarpal Arthroplasty: Comparison of ARPE Prosthesis With the Literature.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01904019
Enrollment
100
Registered
2013-07-19
Start date
2013-04-30
Completion date
2021-05-31
Last updated
2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis

Keywords

arthroplasty, trapezio-metacarpial

Brief summary

This study is designed to document the objective and subjective measurements after trapeziometacarpal athroplasty with ARPE prosthesis and to compare those to literature values of outcome after trapeziectomy and trapeziectomy with ligament reconstruction and tendon interposition (LRTI), as published in a recent meta-analysis.

Detailed description

The primary objective is to compare functional outcome at 3 years after trapezio-metarcarpal arthroplasty with trapeziectomy and trapeziectomy with ligament reconstruction and tendon interposition. Literature values obtained by a recently published meta analysis will be used. The secondary objectives are: * to compare functional outcome at 1 and at 5 years after trapezio-metarcarpal arthroplasty with trapeziectomy and trapeziectomy with ligament reconstruction and tendon interposition * to determine pre- and post-operative HR QOL * Incidence of radiolucencies at each follow up time point. Literature values from the same meta analysis will be used, Patients will be assessed at preoperatively, and at 1, 3 and 5 years postoperatively. Measured Outcomes: grip strength, tip pinch strength, key pinch strength, pain, occurrence of adverse events, hand function.

Interventions

None listed

Sponsors

Biomet Belgium BVBA
CollaboratorINDUSTRY
Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion/

Exclusion criteria

are identical to those indications and contraindications stated in the package insert of the implant. Inclusion Criteria: * patients with trapezio-metacarpal arthritis Eaton Stage of trapezio-metacarpal arthritis: Stage II - IV * patients willing to return for follow up evaluation.

Design outcomes

Primary

MeasureTime frameDescription
Grip StrengthPre-operative, 1, 3 and 5 years follow-upGrip strength is an indicator of muscle health in the hands and forearms and is measured with a hand-held dynamometer. The patients squeeze the dynamometer with all of their strength and the force applied is measured.
Key Pinch StrengthPre-operative, 1, 3 and 5 years follow-upKey pinch strength is an indicator of muscle health and measures the precision grip by using a pinch dynamometer. The device is placed between the radial side of the index finger and thumb and the force applied while the patients pinch as hard as possible is measured.
Tip Pinch StrengthPre-operative, 1, 3 and 5 years follow-upTip pinch strength is an indicator of muscle health and measures the precision grip by using a pinch dynamometer. The device is placed between the tip of the index finger and thumb and the force applied while the patients pinch as hard as possible is measured.
VAS PainPre-operative, 1, 3 and 5 years follow-upPain level is collected with VAS (Visual Analog Scale): the patients are asked to mark their current pain level on a horizontal line containing values ranging from 0 (no pain) to 100 (very severe pain).

Secondary

MeasureTime frameDescription
Number of Implants With Visible Radiolucency Line Around the Implanted Prosthesis1, 3 and 5 years follow-upRadiolucency lines are radiolucent gaps visible in the radiographic images between the prosthesis and the bone, which presence is commonly associated with early failure of the implantation, eventually leading to the loosening of the prosthesis. Every radiography taken at each follow-up time point was assessed to evaluate whether there are visible radiolucency lines around the implanted prosthesis and the number of implants with visible radiolucency lines is here reported.
Hand Function: DASH Questionnaire - DisabilityPre-operative, 1, 3 and 5 years follow-upThe DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.
Motion - ROM Measurement - Radial AbductionPre-operative, 1, 3 and 5 years follow-upThe range of motion (ROM) is the extent of movement of a joint and indicates the range through which the joint can be moved. ROM in radial abduction is measured while the patients move the thumb in parallel to the palm.
Hand Function: DASH Questionnaire - SportPre-operative, 1, 3 and 5 years follow-upThe DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.
Hand Function: DASH Questionnaire - WorkPre-operative, 1, 3 and 5 years follow-upThe DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.
Motion - ROM Measurement - Palmar AbductionPre-operative, 1, 3 and 5 years follow-upThe range of motion (ROM) is the extent of movement of a joint and indicates the range through which the joint can be moved. The ROM in palmar abduction is measured while the patients move the thumb perpendicularly to the palm.
EQ-5D - Health Status ScorePre-operative, 1, 3 and 5 years follow-upEQ-5D is a standardized instrument for measuring the health-related quality of life, which assesses health status in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each question has five levels of response (no problems, slight problems, moderate problems, severe problems, extreme problems/unable to), which are singularly rated and then combined into a health status score. The health status score ranges from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.
EQ-5D - VAS ScorePre-operative, 1, 3 and 5 years follow-upThe second part of the EQ-5D questionnaire consists of a visual analogue scale (VAS) on which the patient rates his/her perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

Countries

Belgium

Participant flow

Pre-assignment details

According to the protocol, 100 subjects were to be enrolled. Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study.

Participants by arm

ArmCount
ARPE Prosthesis
Single study patient cohort, including 95 patients (100 implants) receiving the cementless ARPE trapeziometacarpal prosthesis.
95
ARPE Prosthesis
Single study patient cohort, including 95 patients (100 implants) receiving the cementless ARPE trapeziometacarpal prosthesis.
100
Total195

Withdrawals & dropouts

PeriodReasonFG000
1 Year Follow-upImpossibility to contact patient5
1 Year Follow-upWithdrawal by Subject4
3 Year Follow-upImpossibility to contact patient14
3 Year Follow-upWithdrawal by Subject1
5 Year Follow-upImpossibility to contact patient4
5 Year Follow-upWithdrawal by Subject2

Baseline characteristics

CharacteristicARPE Prosthesis
Age, Continuous62.3 years
STANDARD_DEVIATION 7.2
Height Distribution165.3 cm
STANDARD_DEVIATION 7.4
Other Joint Involvement of the Hand
No
31 implants
Other Joint Involvement of the Hand
Yes
69 implants
Previous Hand Surgeries/Treatments on Affected Hand
No
77 implants
Previous Hand Surgeries/Treatments on Affected Hand
Yes
23 implants
Sex: Female, Male
Female
87 implants
Sex: Female, Male
Male
13 implants
Surgery Side Distribution
Left
59 implants
Surgery Side Distribution
Right
41 implants
Trapezio Metacarpal Arthritis Disease Stage
Stage II
26 implants
Trapezio Metacarpal Arthritis Disease Stage
Stage III
68 implants
Trapezio Metacarpal Arthritis Disease Stage
Stage IV
6 implants
Weight Distribution70.4 kg
STANDARD_DEVIATION 14.5

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 95
other
Total, other adverse events
19 / 95
serious
Total, serious adverse events
17 / 95

Outcome results

Primary

Grip Strength

Grip strength is an indicator of muscle health in the hands and forearms and is measured with a hand-held dynamometer. The patients squeeze the dynamometer with all of their strength and the force applied is measured.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisGrip StrengthPre-operative17.8 kgStandard Deviation 8.7
ARPE ProsthesisGrip Strength1 year follow-up23.4 kgStandard Deviation 9.2
ARPE ProsthesisGrip Strength3 years follow-up24.7 kgStandard Deviation 10.3
ARPE ProsthesisGrip Strength5 years follow-up25 kgStandard Deviation 8.9
Primary

Key Pinch Strength

Key pinch strength is an indicator of muscle health and measures the precision grip by using a pinch dynamometer. The device is placed between the radial side of the index finger and thumb and the force applied while the patients pinch as hard as possible is measured.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisKey Pinch StrengthPre-operative3.6 kgStandard Deviation 2.1
ARPE ProsthesisKey Pinch Strength1 year follow-up5.8 kgStandard Deviation 2.3
ARPE ProsthesisKey Pinch Strength3 years follow-up5.5 kgStandard Deviation 2.1
ARPE ProsthesisKey Pinch Strength5 years follow-up5.9 kgStandard Deviation 2
Primary

Tip Pinch Strength

Tip pinch strength is an indicator of muscle health and measures the precision grip by using a pinch dynamometer. The device is placed between the tip of the index finger and thumb and the force applied while the patients pinch as hard as possible is measured.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisTip Pinch StrengthPre-operative2.7 kgStandard Deviation 1.6
ARPE ProsthesisTip Pinch Strength1 year follow-up4.5 kgStandard Deviation 1.8
ARPE ProsthesisTip Pinch Strength3 years follow-up4.6 kgStandard Deviation 2
ARPE ProsthesisTip Pinch Strength5 years follow-up4.5 kgStandard Deviation 1.5
Primary

VAS Pain

Pain level is collected with VAS (Visual Analog Scale): the patients are asked to mark their current pain level on a horizontal line containing values ranging from 0 (no pain) to 100 (very severe pain).

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisVAS Pain1 year follow-up11.1 score on a scaleStandard Deviation 14.8
ARPE ProsthesisVAS Pain3 years follow-up10.3 score on a scaleStandard Deviation 19.6
ARPE ProsthesisVAS Pain5 years follow-up7.1 score on a scaleStandard Deviation 15.1
ARPE ProsthesisVAS PainPre-operative59.3 score on a scaleStandard Deviation 19.5
Secondary

EQ-5D - Health Status Score

EQ-5D is a standardized instrument for measuring the health-related quality of life, which assesses health status in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each question has five levels of response (no problems, slight problems, moderate problems, severe problems, extreme problems/unable to), which are singularly rated and then combined into a health status score. The health status score ranges from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisEQ-5D - Health Status ScorePre-operative0.4 score on a scaleStandard Deviation 0.3
ARPE ProsthesisEQ-5D - Health Status Score1 year follow-up0.8 score on a scaleStandard Deviation 0.3
ARPE ProsthesisEQ-5D - Health Status Score3 year follow-up0.8 score on a scaleStandard Deviation 0.3
ARPE ProsthesisEQ-5D - Health Status Score5 year follow-up0.8 score on a scaleStandard Deviation 0.3
Secondary

EQ-5D - VAS Score

The second part of the EQ-5D questionnaire consists of a visual analogue scale (VAS) on which the patient rates his/her perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisEQ-5D - VAS ScorePre-operative72.7 score on a scaleStandard Deviation 15.8
ARPE ProsthesisEQ-5D - VAS Score1 year follow-up74.1 score on a scaleStandard Deviation 19.5
ARPE ProsthesisEQ-5D - VAS Score3 years follow-up77.9 score on a scaleStandard Deviation 15.7
ARPE ProsthesisEQ-5D - VAS Score5 years follow-up76.2 score on a scaleStandard Deviation 17.2
Secondary

Hand Function: DASH Questionnaire - Disability

The DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisHand Function: DASH Questionnaire - DisabilityPre-operative41.7 score on a scaleStandard Deviation 17.9
ARPE ProsthesisHand Function: DASH Questionnaire - Disability1 year follow-up10.6 score on a scaleStandard Deviation 14.3
ARPE ProsthesisHand Function: DASH Questionnaire - Disability3 year follow-up10.2 score on a scaleStandard Deviation 14.2
ARPE ProsthesisHand Function: DASH Questionnaire - Disability5 year follow-up8.5 score on a scaleStandard Deviation 11.8
Secondary

Hand Function: DASH Questionnaire - Sport

The DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number. The Sports category is optional.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisHand Function: DASH Questionnaire - SportPre-operative48.7 score on a scaleStandard Deviation 32.4
ARPE ProsthesisHand Function: DASH Questionnaire - Sport1 year follow-up6.7 score on a scaleStandard Deviation 13.4
ARPE ProsthesisHand Function: DASH Questionnaire - Sport3 year follow-up10.1 score on a scaleStandard Deviation 21.8
ARPE ProsthesisHand Function: DASH Questionnaire - Sport5 year follow-up2.2 score on a scaleStandard Deviation 5.8
Secondary

Hand Function: DASH Questionnaire - Work

The DASH (Disabilities of the Arm, Shoulder and Hand) Questionnaire outcome measure is a 30-item, self-report questionnaire designed to assess the patients' health status during the previous week by asking to rate their ability to perform various daily activities. The questions are grouped in 3 categories: disability, work and sport, of which work and sport are optional. The score ranges from 0 (no disability) to 100 (most severe disability), with higher scores indicating a greater level of disability and severity, whereas lower scores indicate a lower level of disability.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number. The Work category is optional.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisHand Function: DASH Questionnaire - WorkPre-operative46.1 score on a scaleStandard Deviation 25.9
ARPE ProsthesisHand Function: DASH Questionnaire - Work1 year follow-up11.1 score on a scaleStandard Deviation 17.2
ARPE ProsthesisHand Function: DASH Questionnaire - Work3 year follow-up7.8 score on a scaleStandard Deviation 16.5
ARPE ProsthesisHand Function: DASH Questionnaire - Work5 year follow-up5.8 score on a scaleStandard Deviation 13.5
Secondary

Motion - ROM Measurement - Palmar Abduction

The range of motion (ROM) is the extent of movement of a joint and indicates the range through which the joint can be moved. The ROM in palmar abduction is measured while the patients move the thumb perpendicularly to the palm.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisMotion - ROM Measurement - Palmar AbductionPre-operative43.2 degreesStandard Deviation 5.8
ARPE ProsthesisMotion - ROM Measurement - Palmar Abduction1 year follow-up48.1 degreesStandard Deviation 6.4
ARPE ProsthesisMotion - ROM Measurement - Palmar Abduction3 years follow-up47.8 degreesStandard Deviation 5.9
ARPE ProsthesisMotion - ROM Measurement - Palmar Abduction5 years follow-up43.4 degreesStandard Deviation 8.4
Secondary

Motion - ROM Measurement - Radial Abduction

The range of motion (ROM) is the extent of movement of a joint and indicates the range through which the joint can be moved. ROM in radial abduction is measured while the patients move the thumb in parallel to the palm.

Time frame: Pre-operative, 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number.

ArmMeasureGroupValue (MEAN)Dispersion
ARPE ProsthesisMotion - ROM Measurement - Radial AbductionPre-operative41.5 degreesStandard Deviation 7.1
ARPE ProsthesisMotion - ROM Measurement - Radial Abduction1 year follow-up53.1 degreesStandard Deviation 37.8
ARPE ProsthesisMotion - ROM Measurement - Radial Abduction3 years follow-up47.5 degreesStandard Deviation 6.1
ARPE ProsthesisMotion - ROM Measurement - Radial Abduction5 years follow-up43.8 degreesStandard Deviation 9.9
Secondary

Number of Implants With Visible Radiolucency Line Around the Implanted Prosthesis

Radiolucency lines are radiolucent gaps visible in the radiographic images between the prosthesis and the bone, which presence is commonly associated with early failure of the implantation, eventually leading to the loosening of the prosthesis. Every radiography taken at each follow-up time point was assessed to evaluate whether there are visible radiolucency lines around the implanted prosthesis and the number of implants with visible radiolucency lines is here reported.

Time frame: 1, 3 and 5 years follow-up

Population: Due to the inclusion of 5 bilateral patients the actual number of participants is 95, but 100 implants were included in the study. The results are indicated per implant number. There were no radiolucency lines reported for any of the patients included in the study at any time point.

ArmMeasureGroupValue (COUNT_OF_UNITS)
ARPE ProsthesisNumber of Implants With Visible Radiolucency Line Around the Implanted Prosthesis1 years follow-up0 implants
ARPE ProsthesisNumber of Implants With Visible Radiolucency Line Around the Implanted Prosthesis3 years follow-up0 implants
ARPE ProsthesisNumber of Implants With Visible Radiolucency Line Around the Implanted Prosthesis5 years follow-up0 implants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026